Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2017-12-18
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. To find out if the leisure activity (soccer) increase the quality of life, motor function, gait function etc..
3. Safety of soccer play in children with cerebral palsy
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Related Lifestyle and Quality of Life in Children With Cerebral Palsy
NCT03277027
Effects of Power Wheelchair Soccer for Individuals Presenting With Physical Impairments
NCT06259643
Effects of Hippotherapy on Physical Fitness and Attention in Cerebral Palsy
NCT03870893
Effect of Physical Activity Intervention Children With Spastic Diplegia After Resistance Training
NCT01367340
Effects of Task Specific Circuit Training on Gross Motor Function, Balance, and Quality of Life in Cerebral Palsy
NCT07283133
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Both the experimental and control group were children with ambulatory cerebral palsy aged 5 to 12 years.
3. Several outcomes were measured before and after the program
* pulmonary function test including FVC, FEV1
* GMFM-88, PBS, walking test, muscle power sprint test, timed up and go, gait parameters
* Child Health Questionnaire Parent Form 50 (CHQ-PF50)
* KIDSCREEN
4. An accelerometer was worn before the program and during the program for a week (experimental group only)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental
children who participated in soccer play program usual activity and therapy + soccer play program (once a week for eight weeks)
soccer play program
once a week for an hour of a soccer program for 8 weeks
control
children without soccer paly program usual activity and therapy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
soccer play program
once a week for an hour of a soccer program for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GMFCS level I-II
* 5-12 years old
Exclusion Criteria
* the behavioral or psychiatric problem that hinders group activity
* intellectual disability to do the questionnaire
* who do not participate in the class well (absent more than 3 times)
5 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Catholic University of Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bo Young Hong
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bo Young Hong
Role: PRINCIPAL_INVESTIGATOR
St. Vincent's hospital, The Catholic University of Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Vincent's hospital
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VC17ONSI0205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.